Buyback yield (TTM)
0.02%
Shareholder yield (TTM)
1.06%
5Y share count change
0.5%
Buyback spend (TTM)
$31.00M
Cumulative buybacks
$4.86B
Key takeaways
- Stryker (SYK) repurchased about $31.00M of stock over the trailing twelve months.
- Diluted share count is roughly flat (0.5%) over the last ~5 fiscal years — buybacks are offsetting dilution but not shrinking the float.
- TTM buyback ÷ stock-based-comp ratio of 0.13× — repurchases only partially offset SBC dilution.
- Cash buyback spend has compounded at -100.0% per year over the latest 5-year window.
- TTM repurchases used about 1% of free cash flow remaining after dividends.
Dividend & buyback yield over time for Stryker (SYK)
Stacked annual yields — buyback yield (TTM cash repurchases ÷ market cap) plus dividend yield from the same fiscal-year-end key-metrics period — show how total cash return per dollar of equity has evolved.
Diluted vs basic shares (annual) for Stryker (SYK)
Diluted weighted-average shares are the EPS denominator — a falling count means buybacks are outpacing SBC dilution.
Year-over-year change in diluted shares for Stryker (SYK)
Green is fewer shares vs the prior fiscal year (net repurchase); red is growth (dilution). The earliest year shown has no prior year to compare.
Cash buyback spend over time for Stryker (SYK)
Latest: $0.00
Overview
The 2025 reading of Stryker (SYK) buyback spend is $0.00 – plunged 100.0% year-over-year.
Stryker buyback spend compound annual growth for the 2020–2025 (5 years) window is -100.0%, with a net decline across the window.
Stryker buyback spend peaked at $1.00B in 2008; the latest annual figure is $0.00 in 2025 (100.0% below peak).
2008 marks the peak buyback spend at $1.00B, with the historical low of $0.00 recorded in 1989.
Stryker Buyback Spend 2025: $0.00
2025's buyback spend for Stryker came in at $0.00, plunged 100.0% below 2024.
Stryker Buyback Spend 2024: $195.00M
Stryker posted buyback spend of $195.00M in 2024, grew 25.8% from 2023.
Stryker Buyback Spend 2023: $155.00M
In 2023, Stryker reported buyback spend of $155.00M, grew 27.0% from 2022.
Stryker Buyback Spend 2022: $122.00M
Stryker buyback spend in 2022 was $122.00M, grew 7.0% from 2021.
Stryker Buyback Spend 2021: $114.00M
Stryker buyback spend in 2021 was $114.00M.
See more financial history for Stryker (SYK).
Buyback, SBC & dilution history
Buyback spend, SBC, net dilution effect, and share count.
| 2025 | $0.00 | $243.00M | −$243.00M | — | 0.38B | -0.9% | |
| 2024 | $195.00M | $229.00M | −$34.00M | 0.14% | 0.39B | +0.5% | |
| 2023 | $155.00M | $205.00M | −$50.00M | 0.14% | 0.38B | +0.4% | |
| 2022 | $122.00M | $168.00M | −$46.00M | 0.13% | 0.38B | -0.0% | |
| 2021 | $114.00M | $171.00M | −$57.00M | 0.11% | 0.38B | +0.5% | |
| 2020 | $110.00M | $142.00M | −$32.00M | 0.12% | 0.38B | +0.1% | |
| 2019 | $307.00M | $127.00M | $180.00M | 0.39% | 0.38B | -0.1% | |
| 2018 | $300.00M | $119.00M | $181.00M | 0.51% | 0.38B | +0.1% | |
| 2017 | $230.00M | $113.00M | $117.00M | 0.40% | 0.38B | +0.4% | |
| 2016 | $13.00M | $97.00M | −$84.00M | 0.03% | 0.38B | -0.6% | |
| 2015 | $700.00M | $86.00M | $614.00M | 2.01% | 0.38B | -0.5% | |
| 2014 | $100.00M | $77.00M | $23.00M | 0.28% | 0.38B | +0.2% | |
| 2013 | $317.00M | $76.00M | $241.00M | 1.11% | 0.38B | -0.2% | |
| 2012 | $108.00M | $75.00M | $33.00M | 0.52% | 0.38B | -1.7% | |
| 2011 | $622.00M | $75.00M | $547.00M | 3.28% | 0.39B | -2.5% | |
| 2010 | $425.50M | $68.80M | $356.70M | 2.03% | 0.40B | +0.0% | |
| 2009 | $0.00 | $62.30M | −$62.30M | — | 0.40B | -3.4% | |
| 2008 | $1.00B | $65.50M | $934.50M | 6.31% | 0.41B | -0.9% | |
| 2007 | $0.00 | $61.30M | −$61.30M | — | 0.42B | +1.4% | |
| 2006 | $0.00 | $49.40M | −$49.40M | — | 0.41B | +0.2% | |
| 2005 | $0.00 | $0.00 | $0.00 | — | 0.41B | +0.4% | |
| 2004 | $0.00 | $0.00 | $0.00 | — | 0.41B | -3.4% | |
| 2003 | $0.00 | $0.00 | $0.00 | — | 0.42B | -0.7% | |
| 2002 | $0.00 | $0.00 | $0.00 | — | 0.43B | +7.1% | |
| 2001 | $0.00 | $0.00 | $0.00 | — | 0.40B | -0.8% | |
| 2000 | $0.00 | $0.00 | $0.00 | — | 0.40B | +3.6% | |
| 1999 | $0.00 | $0.00 | $0.00 | — | 0.39B | -1.4% | |
| 1998 | $0.00 | $0.00 | $0.00 | — | 0.39B | +0.5% | |
| 1997 | $25.60M | $0.00 | $25.60M | — | 0.39B | -0.7% | |
| 1996 | $15.10M | $0.00 | $15.10M | — | 0.39B | — | |
| 1995 | $0.00 | $0.00 | $0.00 | — | — | — | |
| 1994 | $3.10M | $0.00 | $3.10M | — | — | — | |
| 1993 | $0.00 | $0.00 | $0.00 | — | — | — | |
| 1992 | $0.00 | $0.00 | $0.00 | — | — | — | |
| 1991 | $0.00 | $0.00 | $0.00 | — | — | — | |
| 1990 | $0.00 | $0.00 | $0.00 | — | — | — | |
| 1989 | $0.00 | $0.00 | $0.00 | — | — | — |
- 2025$0.00
- 2024$195.00M
- 2023$155.00M
- 2022$122.00M
- 2021$114.00M
- 2020$110.00M
- 2019$307.00M
- 2018$300.00M
- 2017$230.00M
- 2016$13.00M
- 2015$700.00M
- 2014$100.00M
- 2013$317.00M
- 2012$108.00M
- 2011$622.00M
- 2010$425.50M
- 2009$0.00
- 2008$1.00B
- 2007$0.00
- 2006$0.00
- 2005$0.00
- 2004$0.00
- 2003$0.00
- 2002$0.00
- 2001$0.00
- 2000$0.00
- 1999$0.00
- 1998$0.00
- 1997$25.60M
- 1996$15.10M
- 1995$0.00
- 1994$3.10M
- 1993$0.00
- 1992$0.00
- 1991$0.00
- 1990$0.00
- 1989$0.00
Buybacks vs stock-based compensation for Stryker (SYK)
Annual cash repurchases set against stock-based compensation. Coverage above 1× means buybacks fully offset the equity dilution from SBC. TTM coverage: 0.13×.
Buybacks vs dividends (share of cash returned) for Stryker (SYK)
How Stryker splits cash returned to shareholders between dividends and buybacks.
Sector peers by buyback spend
Companies in the same sector as Stryker, ranked by their latest buyback spend.
| $5.95B | |
| $5.54B | |
| $5.08B | |
| $4.11B | |
| $980.00M | |
| $216.35M | |
| $0.00 | |
| $0.00 |
- $5.95B
- $5.54B
- $5.08B
- $4.11B
- $980.00M
- $216.35M
- $0.00
- $0.00
Buyback capacity (TTM)
Free cash flow minus dividends paid versus actual TTM repurchases — the headroom bar shows how much of post-dividend FCF is still being deployed elsewhere.
Headroom $3.27B (TTM FCF − TTM dividends, clamped at zero).
Frequently asked questions
Data & methodology
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation